Amamoto R, Arlotta P. Development-inspired reprogramming of the mammalian central nervous system. Science. 2014;343(6170):1239882. doi:10.1126/science.1239882
Salter MW, Stevens B. Microglia emerge as central players in brain disease. Nat Med. 2017;23(9):1018-1027. doi:10.1038/nm.4397
Nyegaard M, Severinsen JE, Als TD, et al. Support of association between BRD1 and both schizophrenia and bipolar affective disorder. Am J Med Genet B Neuropsychiatr Genet. 2010;153B(2):582-591. doi:10.1002/ajmg.b.31023
Chouraki V, Preis SR, Yang Q, et al. Association of amine biomarkers with incident dementia and Alzheimer’s disease in the Framingham Study. Alzheimers Dement. 2017;13(12):1327-1336. doi:10.1016/j.jalz.2017.04.009
Yu L, Lutz MW, Farfel JM, et al. Neuropathologic features of TOMM40 ’523 variant on late-life cognitive decline. Alzheimers Dement. 2017;13(12):1380-1388. doi:10.1016/j.jalz.2017.05.002
Singh T, Walters JTR, Johnstone M, et al. The contribution of rare variants to risk of schizophrenia in individuals with and without intellectual disability. Nat Genet. 2017;49(8):1167-1173. doi:10.1038/ng.3903
Bauer J, Becker AJ, Elyaman W, et al. Innate and adaptive immunity in human epilepsies. Epilepsia. 2017;58 Suppl 3:57-68. doi:10.1111/epi.13784
Kaczorowski KJ, Shekhar K, Nkulikiyimfura D, et al. Continuous immunotypes describe human immune variation and predict diverse responses. Proc Natl Acad Sci U S A. 2017;114(30):E6097-E6106. doi:10.1073/pnas.1705065114
Porta-Pardo E, Kamburov A, Tamborero D, et al. Comparison of algorithms for the detection of cancer drivers at subgene resolution. Nat Methods. 2017;14(8):782-788. doi:10.1038/nmeth.4364
Tsuji H, Yano K, Furu M, et al. Time-averaged disease activity fits better joint destruction in rheumatoid arthritis. Sci Rep. 2017;7(1):5856. doi:10.1038/s41598-017-05581-w